δ-Opioid receptor as a target for the creation of peptide drugs that increase cardiac resistance to reperfusion

An analysis of published data and the results of our own studies showed that activation of peripheral δ2-opioid receptor (δ2-OR) increases cardiac tolerance to reperfusion. It has been established that this δ2-OR is localized in cardiomyocytes. Endogenous opioids are not involved in the regulation of cardiac resistance to reperfusion in non-adapted rats. The infarct-limiting effect of δ2-OR agonist deltorphin II depends on the activation of following protein kinases: PKCδ, ERK1/2, PI3K, PCG. SarcKATP channel and MPT pore are hypothetical end effectors of the cardioprotective effect of deltorphin II.

[1]  Nirmal Singh,et al.  The Infarct-Reducing Effect of the δ2 Opioid Receptor Agonist Deltorphin II: The Molecular Mechanism , 2023, Membranes.

[2]  Jinjing Xu,et al.  The dual role and mutual dependence of heme/HO-1/Bach1 axis in the carcinogenic and anti-carcinogenic intersection , 2022, Journal of Cancer Research and Clinical Oncology.

[3]  E. Martin,et al.  Soluble guanylyl cyclase: Molecular basis for ligand selectivity and action in vitro and in vivo , 2022, Frontiers in Molecular Biosciences.

[4]  Ya-Qun Zhou,et al.  Targeting the nitric oxide/cGMP signaling pathway to treat chronic pain , 2022, Neural regeneration research.

[5]  A. Boshchenko,et al.  Reperfusion Cardiac Injury: Receptors and the Signaling Mechanisms , 2022, Current cardiology reviews.

[6]  P. Oeltgen,et al.  Activation of peripheral δ2-opioid receptor prevents reperfusion heart injury. , 2021, European journal of pharmacology.

[7]  José Luis Bernal,et al.  Sex bias in admission to tertiary‐care centres for acute myocardial infarction and cardiogenic shock , 2021, European journal of clinical investigation.

[8]  Anas M. Saad,et al.  National trends of utilization and readmission rates with intravascular ultrasound use for ST‐elevation myocardial infarction , 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[9]  M. C. Isoldi,et al.  Pre- and post-conditioning of the heart: an overview of cardioprotective signaling pathways. , 2020, Current vascular pharmacology.

[10]  E. Brilakis,et al.  Use of intravascular imaging in patients with ST-segment elevation acute myocardial infarction. , 2020, Cardiovascular revascularization medicine : including molecular interventions.

[11]  A. Jaggi,et al.  The Role of Natriuretic Peptides in the Regulation of Cardiac Tolerance to Ischemia/Reperfusion and Postinfarction Heart Remodeling , 2020, Journal of cardiovascular pharmacology and therapeutics.

[12]  C. Schmidt,et al.  Temporal changes in patient characteristics and outcomes in ST‐segment elevation myocardial infarction 2003–2018 , 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[13]  J. Downey,et al.  Reactive Oxygen Species as Intracellular Signaling Molecules in the 
Cardiovascular System , 2018, Current cardiology reviews.

[14]  D. Acharya.  Predictors of Outcomes in Myocardial Infarction and Cardiogenic Shock , 2018, Cardiology in review.

[15]  Юрий Борисович Лишманов,et al.  Проницаемость гематоэнцефалического барьера для опиоидных пептидов , 2017 .

[16]  Shufang He,et al.  Spinal Neuronal NOS Signaling Contributes to Morphine Cardioprotection in Ischemia Reperfusion Injury in Rats , 2016, The Journal of Pharmacology and Experimental Therapeutics.

[17]  J. Downey,et al.  Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists , 2016, Medicinal research reviews.

[18]  A. Heinen,et al.  Morphine-Induced Preconditioning: Involvement of Protein Kinase A and Mitochondrial Permeability Transition Pore , 2016, PloS one.

[19]  Mireia Carcolé,et al.  The antinociceptive effects of a δ-opioid receptor agonist in mice with painful diabetic neuropathy: Involvement of heme oxygenase 1 , 2016, Neuroscience Letters.

[20]  G. Heusch.  Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning. , 2015, Circulation research.

[21]  A. Hsu,et al.  Acute and Chronic Cardioprotection by the Enkephalin Analogue, Eribis Peptide 94, is Mediated via Activation of Nitric Oxide Synthase and Adenosine Triphosphate-Regulated Potassium Channels , 2012, Pharmacology.

[22]  Bo Zhang,et al.  U50,488H inhibits neutrophil accumulation and TNF-α induction induced by ischemia-reperfusion in rat heart. , 2011, Cytokine.

[23]  Tianzuo Li,et al.  Involvement of adenosine monophosphate-activated protein kinase in morphine-induced cardioprotection. , 2011, The Journal of surgical research.

[24]  Mi Young Lee,et al.  Morphine-induced postconditioning modulates mitochondrial permeability transition pore opening via delta-1 opioid receptors activation in isolated rat hearts , 2011, Korean journal of anesthesiology.

[25]  Mi Young Lee,et al.  Kappa-opioid receptor activation during reperfusion limits myocardial infarction via ERK1/2 activation in isolated rat hearts , 2011, Korean journal of anesthesiology.

[26]  F. Drago,et al.  Morphine-induced ocular hypotension is modulated by nitric oxide and carbon monoxide: role of mu3 receptors. , 2010, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[27]  A. Hsu,et al.  Acute Methadone Treatment Reduces Myocardial Infarct Size via the &dgr;-Opioid Receptor in Rats During Reperfusion , 2009, Anesthesia and analgesia.

[28]  P. Oeltgen,et al.  Activation of peripheral delta2 opioid receptors increases cardiac tolerance to ischemia/reperfusion injury Involvement of protein kinase C, NO-synthase, KATP channels and the autonomic nervous system. , 2009, Life sciences.

[29]  Shumiao Zhang,et al.  Myocardial apoptosis and infarction after ischemia/reperfusion are attenuated by kappa-opioid receptor agonist. , 2009, Archives of medical research.

[30]  A. Hsu,et al.  Activation of kappa-opioid receptors at reperfusion affords cardioprotection in both rat and mouse hearts , 2008, Basic Research in Cardiology.

[31]  R. Mueller,et al.  Postconditioning Prevents Reperfusion Injury by Activating &dgr;-Opioid Receptors , 2008, Anesthesiology.

[32]  H. Patel,et al.  Reactive oxygen species trigger ischemic and pharmacological postconditioning: in vivo and in vitro characterization. , 2007, Life sciences.

[33]  A. Hsu,et al.  The JAK/STAT pathway is essential for opioid-induced cardioprotection: JAK2 as a mediator of STAT3, Akt, and GSK-3 beta. , 2006, American journal of physiology. Heart and circulatory physiology.

[34]  M. Irwin,et al.  Remifentanil mimics cardioprotective effect of ischemic preconditioning via protein kinase C activation in open chest of rats , 2005, Acta Pharmacologica Sinica.

[35]  A. Hsu,et al.  Opioid-Induced Cardioprotection Occurs via Glycogen Synthase Kinase β Inhibition During Reperfusion in Intact Rat Hearts , 2004, Circulation research.

[36]  G. Gross,et al.  &dgr;‐Opioid Receptor Activation Mimics Ischemic Preconditioning in the Canine Heart , 2003, Journal of cardiovascular pharmacology.

[37]  R. Fryer,et al.  Dependence of delta1-opioid receptor-induced cardioprotection on a tyrosine kinase-dependent but not a Src-dependent pathway. , 2001, The Journal of pharmacology and experimental therapeutics.

[38]  A. Hsu,et al.  BW373U86, a delta opioid agonist, partially mediates delayed cardioprotection via a free radical mechanism that is independent of opioid receptor stimulation. , 2001, Journal of molecular and cellular cardiology.

[39]  L. Maslov,et al.  Prevention of experimental epinephrine-induced arrhythmias with agonists of δ1- and δ2-opiate receptors , 1997, Bulletin of Experimental Biology and Medicine.

[40]  L. Maslov,et al.  The anti-arrhythmic effect of D-Ala 2, Leu 5, Arg 6-enkephalin and its possible mechanism. , 1993, International journal of cardiology.

[41]  G. Wong,et al.  Remote intrathecal morphine preconditioning confers cardioprotection via spinal cord nitric oxide/cyclic guanosine monophosphate/protein kinase G pathway. , 2015, The Journal of surgical research.

[42]  Садыкова Юлия Жавитовна.  Современное состояние системы здравоохранения Российской Федерации , 2014 .

[43]  Вадим Васильевич Свиридов,et al.  Научно-исследовательский институт физико-химических проблем Белгосуниверситета: создание, становление, развитие, перспективы , 1998 .

[44]  В. Г. Колб,et al.  Справочник по клинической химии , 1982 .